Sign Out
Deltyba is indicated for use as part of an appropriate combination regimen for pulmonary multi-drug resistant tuberculosis (MDR-TB) in adults, adolescents and children with a body weight of at least 30 kg when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability (see Dosage & Administration, Precautions and Pharmacology: Pharmacodynamics under Actions).
Consideration should be given to official guidance on the appropriate use of antibacterial agents.
Continue with Google